Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quarterly by end of week

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 27, 2021 11:22am

208 Views

Post# 33775739

RE:RE:RE:RE:Quarterly by end of week

Who knows all speculation. Maybe negotiations were under place and partner wanted someone else to deal with, so they hired new COO. Maybe we will never know?

socksnblonds642 wrote:

Ahhhh, kind of like "Does your dog bite sir"...it's not this week I guess.

There must be a lot of info to disseminate properly!! This next release when it does come will tell us a lot either way. Hopefully not by omission.

Still think Oden was on to something with the cessation of insider buying. It is a key marker for something big. Albeit we don't know if it's good or bad yet.